Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 5Neoplasms 4Prostatic Neoplasms 3Oligodendroglioma 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Multiple Myeloma 2Melanoma 2Glioma 2Glioblastoma 2Esophageal Neoplasms 2Brain Neoplasms 2Astrocytoma 2Anus Neoplasms 2Weight Loss 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1Thymus Neoplasms 1Thrombocytopenia 1Testicular Neoplasms 1Stomach Neoplasms 1Splenomegaly 1Skin Neoplasms 1

Interventions

Exercise 4Walking 2Memantine 2Donepezil 2beta Carotene 1Vitamin E 1Ultraviolet Therapy 1Time 1Tai Ji 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Sirolimus 1Riluzole 1Rehabilitation, Vocational 1Referral and Consultation 1Ramipril 1Radiotherapy, Intensity-Modulated 1Quality of Life 1Population Groups 1Pioglitazone 1Palliative Care 1Neuropsychological Tests 1Mindfulness-Based Stress Reduction 1Methods 1Interviews as Topic 1Ibuprofen 1Hormones 1Hematologic Tests 1Geritol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cognitive Dysfunction × Quality of Life × Clear all
NCT04708548 2023-05-15

Long Term Implications of Rare Brain Tumours'

University of Leeds

Completed
267 enrolled
CNS

Oligodendroglioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡